Cargando…

Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications – A pilot study

BACKGROUND: Antibody responses to SARS-CoV-2 vaccination are impaired in people with multiple sclerosis (MS) under anti-CD20 therapies. It is however unclear, whether patients who received the basic immunization prior to anti-B cell medication start respond to the COVID-19 booster dose, once B cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moser, Tobias, Otto, Ferdinand, O'Sullivan, Ciara, Hitzl, Wolfgang, Pilz, Georg, Harrer, Andrea, Trinka, Eugen, Wipfler, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785406/ https://www.ncbi.nlm.nih.gov/pubmed/35093840 http://dx.doi.org/10.1016/j.msard.2022.103560

Ejemplares similares

Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study
por: Moser, Tobias, et al.
Publicado: (2022)

Pre-Existing Humoral Immunological Memory Is Retained in Patients with Multiple Sclerosis Receiving Cladribine Therapy
por: Moser, Tobias, et al.
Publicado: (2021)

The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF
por: Harrer, Christine, et al.
Publicado: (2021)

Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study
por: Pilz, Georg, et al.
Publicado: (2019)

Chemokine CXCL13 in serum, CSF and blood–CSF barrier function: evidence of compartment restriction
por: Pilz, Georg, et al.
Publicado: (2020)

Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery
por: Feige, Julia, et al.
Publicado: (2022)

Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting
por: Seiberl, Michael, et al.
Publicado: (2023)

Immunomodulatory Aspects of Therapeutic Plasma Exchange in Neurological Disorders—A Pilot Study
por: Foettinger, Fabian, et al.
Publicado: (2023)

Lymphocyte Subsets Show Different Response Patterns to In Vivo Bound Natalizumab—A Flow Cytometric Study on Patients with Multiple Sclerosis
por: Harrer, Andrea, et al.
Publicado: (2012)

The CXCL13/CXCR5 Immune Axis in Health and Disease—Implications for Intrathecal B Cell Activities in Neuroinflammation
por: Harrer, Christine, et al.
Publicado: (2022)

Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients
por: Moser, Tobias, et al.
Publicado: (2021)

Role and Relevance of Cerebrospinal Fluid Cells in Diagnostics and Research: State-of-the-Art and Underutilized Opportunities
por: Otto, Ferdinand, et al.
Publicado: (2021)

Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod
por: Harrer, Andrea, et al.
Publicado: (2015)

Tick-Borne Encephalitis Virus RNA Found in Frozen Goat’s Milk in a Family Outbreak
por: Mylonaki, Eirini, et al.
Publicado: (2022)

Misinterpretation of glioblastoma as ADEM: potentially harmful consequences of over-diagnosis of COVID-19 vaccine-associated adverse events
por: O´Sullivan, C., et al.
Publicado: (2021)

Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study
por: Karamyan, Anush, et al.
Publicado: (2016)

Therapeutic Plasma Exchange in Multiple Sclerosis and Autoimmune Encephalitis: A Comparative Study of Indication, Efficacy, and Safety
por: Moser, Tobias, et al.
Publicado: (2019)

Response of T-cell Subpopulations to Superantigen and Recall Antigen Stimulation in Systemic Sclerosis
por: Dar, Sajad Ahmad, et al.
Publicado: (2012)

Projected Numbers of Ischemic Strokes Recorded in the Austrian Stroke-Unit Registry from 2012 to 2075
por: Hitzl, Wolfgang, et al.
Publicado: (2016)

Non-convulsive status epilepticus with right arm apraxia: A case report
por: Ladisich, Barbara, et al.
Publicado: (2020)

NK Cell-Mediated Recall Responses: Memory-Like, Adaptive, or Antigen-Specific?
por: Stary, Victoria, et al.
Publicado: (2020)

Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis
por: Schwarz, Tatjana, et al.
Publicado: (2022)

Ex Vivo Blockade of the PD-1 Pathway Improves Recall IFNγ Responses of HIV-Infected Persons on Antiretroviral Therapy
por: Fischhaber, Natalie, et al.
Publicado: (2023)

Hydroxychloroquine reduces T cells activation recall antigen responses
por: Kowatsch, Monika M., et al.
Publicado: (2023)

(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study
por: Höfler, Julia, et al.
Publicado: (2016)

The Direct Testing Effect Is Pervasive in Action Memory: Analyses of Recall Accuracy and Recall Speed
por: Kubik, Veit, et al.
Publicado: (2018)

Randomized study of teriflunomide effects on immune responses to neoantigen and recall antigens
por: Bar-Or, Amit, et al.
Publicado: (2015)

Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants
por: Budroni, Sonia, et al.
Publicado: (2021)

The Preservation of Cued Recall in the Acute Mentally Fatigued State: A Randomised Crossover Study
por: Flindall, Ian Richard, et al.
Publicado: (2015)

Accuracy of Recalled Body Weight – A Study with 20-years of Follow-up
por: Dahl, Anna K, et al.
Publicado: (2013)

Isodose 20 Gy found as a threshold dose for radiation recall dermatitis
por: Scher, N., et al.
Publicado: (2019)

Overcoming Endocrine Resistance in Hormone-Receptor Positive Advanced Breast Cancer-The Emerging Role of CDK4/6 Inhibitors
por: O’Sullivan, Ciara C
Publicado: (2015)

Salzburg criteria for nonconvulsive status epilepticus: Details matter
por: Leitinger, Markus, et al.
Publicado: (2019)

Risk Factors for Intensive Care Unit Admission in Patients with Autoimmune Encephalitis
por: Harutyunyan, Gayane, et al.
Publicado: (2017)

Tract-specific MRI measures explain learning and recall differences in multiple sclerosis
por: Winter, Mia, et al.
Publicado: (2021)

Can teleconsent improve patient recall of surgical risks in knee arthroplasty? A randomised controlled trial
por: Turner, Henry, et al.
Publicado: (2022)

Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNβ-Therapy
por: Mehling, Matthias, et al.
Publicado: (2013)

Proliferation assay amplification by IL-2 in model primary and recall antigen systems
por: Kennell, Amy SM, et al.
Publicado: (2014)

Interleukin-7 Unveils Pathogen-Specific T Cells by Enhancing Antigen-Recall Responses
por: Terrazzini, Nadia, et al.
Publicado: (2018)

FDA reports recall of Innova COVID-19 antigen rapid qualitative test
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lpa3gmip03u4b0rn9tmoc2uer6